Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Evaluation of mutation profiling by matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry in fine needle aspirations from papillary thyroid cancer.

Woo HI, Kim SW, Ki CS, Shin JH, Oh YL, Kim JW, Chung JH.

Clin Chem Lab Med. 2014 Jul;52(7):e139-42. doi: 10.1515/cclm-2013-1007. No abstract available.

PMID:
24561361
2.

An alternative approach in endocrine pathology research: MALDI-IMS in papillary thyroid carcinoma.

Mainini V, Pagni F, Garancini M, Giardini V, De Sio G, Cusi C, Arosio C, Roversi G, Chinello C, Caria P, Vanni R, Magni F.

Endocr Pathol. 2013 Dec;24(4):250-3. doi: 10.1007/s12022-013-9273-8. No abstract available.

PMID:
24142502
3.

Proteomic study of thyroid tumors reveals frequent up-regulation of the Ca2+ -binding protein S100A6 in papillary thyroid carcinoma.

Sofiadis A, Dinets A, Orre LM, Branca RM, Juhlin CC, Foukakis T, Wallin G, Höög A, Hulchiy M, Zedenius J, Larsson C, Lehtiö J.

Thyroid. 2010 Oct;20(10):1067-76. doi: 10.1089/thy.2009.0400.

PMID:
20629554
4.

BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population.

Kim SW, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH.

J Clin Endocrinol Metab. 2010 Aug;95(8):3693-700. doi: 10.1210/jc.2009-2795. Epub 2010 May 25.

PMID:
20501689
5.

Imaging mass spectrometry in papillary thyroid carcinoma for the identification and validation of biomarker proteins.

Min KW, Bang JY, Kim KP, Kim WS, Lee SH, Shanta SR, Lee JH, Hong JH, Lim SD, Yoo YB, Na CH.

J Korean Med Sci. 2014 Jul;29(7):934-40. doi: 10.3346/jkms.2014.29.7.934. Epub 2014 Jul 11.

6.

BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.

Rossi ED, Martini M, Capodimonti S, Lombardi CP, Pontecorvi A, Vellone VG, Zannoni GF, Larocca LM, Fadda G.

Cancer Cytopathol. 2013 Jun;121(6):291-7. doi: 10.1002/cncy.21258. Epub 2012 Nov 28.

7.

BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.

Zatelli MC, Trasforini G, Leoni S, Frigato G, Buratto M, Tagliati F, Rossi R, Cavazzini L, Roti E, degli Uberti EC.

Eur J Endocrinol. 2009 Sep;161(3):467-73. doi: 10.1530/EJE-09-0353. Epub 2009 Jul 2.

8.

BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.

Chang H, Lee H, Yoon SO, Kim H, Kim A, Kim BH.

Hum Pathol. 2012 Jan;43(1):89-95. doi: 10.1016/j.humpath.2011.04.010. Epub 2011 Jul 19.

PMID:
21774961
9.

Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.

Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE.

Acta Cytol. 2011;55(6):576-83. doi: 10.1159/000333453. Epub 2011 Dec 9.

PMID:
22156469
10.

The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.

Paulson L, Shindo M, Schuff K, Corless C.

Arch Otolaryngol Head Neck Surg. 2012 Jan;138(1):44-9. doi: 10.1001/archoto.2011.226.

PMID:
22249628
11.

Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.

Dyhdalo K, Macnamara S, Brainard J, Underwood D, Tubbs R, Yang B.

Cancer Cytopathol. 2014 Feb;122(2):114-22. doi: 10.1002/cncy.21356. Epub 2013 Oct 21.

12.

Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation.

Kim SK, Lee JH, Woo JW, Park I, Choe JH, Kim JH, Kim JS.

Medicine (Baltimore). 2015 May;94(21):e760. doi: 10.1097/MD.0000000000000760.

13.

[Use of BRAF V600E mutation in the differential diagnosis of follicular and papillary tumors of the thyroid and for the optimization of thearpy].

Semënov DIu, Boriskova ME, Zaraĭskiĭ MI, Saburova IIu, Pankova PA, Farafonova UV, Bykov MA.

Vopr Onkol. 2012;58(5):649-52. Russian.

PMID:
23600282
14.
15.

Papillary thyroid carcinoma with BRAFV600E mutation: sonographic prediction.

Hwang J, Shin JH, Han BK, Ko EY, Kang SS, Kim JW, Chung JH.

AJR Am J Roentgenol. 2010 May;194(5):W425-30. doi: 10.2214/AJR.09.3512.

PMID:
20410389
16.

Cytomorphological factors and BRAF mutation predicting risk of lymph node metastasis in preoperative liquid-based fine needle aspirations of papillary thyroid carcinoma.

Chung SY, Lee JS, Lee H, Park SH, Kim SJ, Ryu HS.

Acta Cytol. 2013;57(3):252-8. doi: 10.1159/000343617. Epub 2013 Apr 25.

PMID:
23636013
17.

Proteome analysis identified maspin as a special feature of papillary thyroid carcinoma.

Boltze C, Schneider-Stock R, Quednow C, Gerlach R, Mawrin C, Hinze R, Roessner A, Hoang-Vu C.

Int J Oncol. 2003 Nov;23(5):1323-8.

PMID:
14532972
18.

A molecular expression signature distinguishing follicular lesions in thyroid carcinoma using preamplification RT-PCR in archival samples.

Denning KM, Smyth PC, Cahill SF, Finn SP, Conlon E, Li J, Flavin RJ, Aherne ST, Guenther SM, Ferlinz A, O'Leary JJ, Sheils OM.

Mod Pathol. 2007 Oct;20(10):1095-102. Epub 2007 Jul 27.

19.

Molecular genotyping of follicular variant of papillary thyroid carcinoma correlates with diagnostic category of fine-needle aspiration cytology: values of RAS mutation testing.

Lee SR, Jung CK, Kim TE, Bae JS, Jung SL, Choi YJ, Kang CS.

Thyroid. 2013 Nov;23(11):1416-22. doi: 10.1089/thy.2012.0640. Epub 2013 Jul 25.

20.

Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Amann JM, Chaurand P, Gonzalez A, Mobley JA, Massion PP, Carbone DP, Caprioli RM.

Clin Cancer Res. 2006 Sep 1;12(17):5142-50.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk